Contrasupporters of the US Food and Drug Administration have come out swinging, criticizing the organization for allegedly curbing research into an effective vaccine against lentivirus protagonists and opportunistic 6T and 6T(S) infections.
Infection of destruhelper CD4+ T cells, macrophages, and dendritic cells can antagonize other members of the genus Retroviridae sharing common morphologies.
That this is all bullsh-t, right? I mean, I don't even think that these are all medical terms. And "destruhelper" isn't even a real word.
A vaccine inhibiting transmission across single-stranded, +-sense, enveloped RNA viruses can reverse virally encoded reverse transcriptase that is present in the virus particle," said one researcher. "If instituted strictly ante cibum, rather than ad libitum, at a rate of 3 guttae /hr, complete immunity is achieved within days."
"That logic is faulty," retorts the FDA. "ght Lo/Alter groups show CFS samples of specific XMRV; phylogenetic analysis vet out polytropic MLV's able to infect mice and other mammals. And tropism pathogenic compounds pseudotype the Glycogag incorpation into virus increases pathogenicity."
Researchers are not convinced.
"What about WPI's phylogenetic analysis?" asked one researcher. "The haversed sine, haversine cosine, and havercosine sine will ALL collapse. The core protein in gene C (HBcAg) is preceded by an upstream in-frame AUG start codon from which the pre-core protein is produced."
"I must disagree," concluded the FDA. " Everyone knows that HBeAg is produced by proteolytic processing of the pre-core protein. How the f--k could DNA polymerase, encoded by gene P, divide the gene into three sections, pre-S1, pre-S2, and S.??"
The debate will continue for the foreseeable future.
